Premium accounts now available! Sign up and create a premium account. Read more Close

Advertisement

Image

[Articles] Cagrilintide–semaglutide (CagriSema) as an add-on to basal insulin in adults with type 2 diabetes (REIMAGINE 3): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study

Journal content Created on 08 Jun 2026 The Lancet

Julio Rosenstock, Liana K Billings, Reena Gajria, Francesco Giorgino, Nanna Borup Johansen, Klara R Klein, Usha K Thamattoor, John B Buse, Akshay B Jain

Advertisement

Stats

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 45
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement